Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LUCENTIS vs LURBINECTEDIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LUCENTIS vs LURBINECTEDIN: Safety Overview

Metric LUCENTIS LURBINECTEDIN
Total FAERS Reports 686 966
Deaths Reported 184 252
Death Rate 26.8% 26.1%
Hospitalizations 180 337
Average Patient Age 71.6 yrs 64.5 yrs
% Female Patients N/A 42.9%
FDA Approval Date N/A Jun 15, 2020
Manufacturer N/A Jazz Pharmaceuticals, Inc.
Route N/A INTRAVENOUS
Marketing Status N/A Prescription